
Colfax Corporation – NYSE:CFX
Colfax stock price today
Colfax stock price monthly change
Colfax stock price quarterly change
Colfax stock price yearly change
Colfax key metrics
Market Cap | 2.12B |
Enterprise value | 3.69B |
P/E | 28.55 |
EV/Sales | 0.92 |
EV/EBITDA | 7.80 |
Price/Sales | 0.52 |
Price/Book | 0.45 |
PEG ratio | 0.55 |
EPS | -1.49 |
Revenue | 1.81B |
EBITDA | 129.57M |
Income | -81.90M |
Revenue Q/Q | 27.11% |
Revenue Y/Y | 14.02% |
Profit margin | 1.69% |
Oper. margin | 6.41% |
Gross margin | 41.84% |
EBIT margin | 6.41% |
EBITDA margin | 7.13% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeColfax stock price history
Colfax stock forecast
Colfax financial statements
Jun 2023 | 428.50M | -9.99M | -2.33% |
---|---|---|---|
Sep 2023 | 417.52M | -2.88M | -0.69% |
Dec 2023 | 455.02M | 2.96M | 0.65% |
Mar 2024 | 516.26M | -71.99M | -13.95% |
2021-02-18 | 0.5 | 0.51 |
---|---|---|
2021-04-29 | 0.4 | 0.44 |
2021-07-28 | 0.53 | 0.56 |
2021-11-04 | 0.54 | 0.54 |
Jun 2023 | 4443553000 | 992.79M | 22.34% |
---|---|---|---|
Sep 2023 | 4400917000 | 959.18M | 21.8% |
Dec 2023 | 4509334000 | 1.08B | 24.14% |
Mar 2024 | 5478681000 | 2.16B | 39.57% |
Jun 2023 | 28.10M | -131.60M | 114.21M |
---|---|---|---|
Sep 2023 | 31.01M | -17.10M | -13.70M |
Dec 2023 | 68.41M | -59.37M | 2.78M |
Mar 2024 | -36.15M | -797.84M | 864.54M |
Colfax alternative data
Aug 2023 | 16,200 |
---|---|
Sep 2023 | 16,200 |
Oct 2023 | 16,200 |
Nov 2023 | 16,200 |
Dec 2023 | 16,200 |
Jan 2024 | 16,200 |
Feb 2024 | 16,200 |
Mar 2024 | 16,200 |
Apr 2024 | 16,200 |
May 2024 | 16,200 |
Jun 2024 | 16,200 |
Jul 2024 | 16,200 |
Colfax other data
Period | Buy | Sel |
---|---|---|
May 2021 | 0 | 224677 |
Jul 2021 | 0 | 150000 |
Aug 2021 | 250200 | 302892 |
Sep 2021 | 0 | 121339 |
Oct 2021 | 0 | 89862 |
Nov 2021 | 0 | 80801 |
Dec 2021 | 0 | 6711 |
Feb 2022 | 0 | 222655 |
Mar 2022 | 0 | 26979 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Sale | PRYOR DANIEL A officer: EVP, Str.. | Common stock, par value $.001 | 3,463 | $38.88 | $134,641 | ||
Sale | PRYOR DANIEL A officer: EVP, Str.. | Common stock, par value $.001 | 3,463 | $38.88 | $134,641 | ||
Sale | PRYOR DANIEL A officer: EVP, Str.. | Common stock, par value $.001 | 3,463 | $38.88 | $134,641 | ||
Sale | KAMBEYANDA SHYAM officer: ESAB Pre.. | Common stock, par value $.001 | 2,788 | $38.88 | $108,397 | ||
Sale | KAMBEYANDA SHYAM officer: ESAB Pre.. | Common stock, par value $.001 | 2,788 | $38.88 | $108,397 | ||
Sale | KAMBEYANDA SHYAM officer: ESAB Pre.. | Common stock, par value $.001 | 2,788 | $38.88 | $108,397 | ||
Sale | LANG PATRICIA A officer: SVP, Chief HR Officer | Common stock, par value $.001 | 1,425 | $38.88 | $55,404 | ||
Sale | TANDY BRADLEY J officer: SVP, Gen.. | Common stock, par value $.001 | 1,498 | $38.88 | $58,242 | ||
Sale | TREROTOLA MATTHEW L. director, officer.. | Common stock, par value $.001 | 12,002 | $38.88 | $466,638 | ||
Sale | TREROTOLA MATTHEW L. director, officer.. | Common stock, par value $.001 | 12,002 | $38.88 | $466,638 |
Quarter | Transcript |
---|---|
Q4 2021 22 Feb 2022 | Q4 2021 Earnings Call Transcript |
Q3 2021 7 Nov 2021 | Q3 2021 Earnings Call Transcript |
Q2 2021 30 Jul 2021 | Q2 2021 Earnings Call Transcript |
Q1 2021 1 May 2021 | Q1 2021 Earnings Call Transcript |
-
What's the price of Colfax stock today?
One share of Colfax stock can currently be purchased for approximately $39.06.
-
When is Colfax's next earnings date?
Unfortunately, Colfax's (CFX) next earnings date is currently unknown.
-
Does Colfax pay dividends?
No, Colfax does not pay dividends.
-
How much money does Colfax make?
Colfax has a market capitalization of 2.12B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 9.22% to 1.71B US dollars. Colfax made a loss 33.26M US dollars in net income (profit) last year or $0.54 on an earnings per share basis.
-
What is Colfax's stock symbol?
Colfax Corporation is traded on the NYSE under the ticker symbol "CFX".
-
What is Colfax's primary industry?
Company operates in the Industrials sector and Industrial - Machinery industry.
-
How do i buy shares of Colfax?
Shares of Colfax can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Colfax's key executives?
Colfax's management team includes the following people:
- Mr. Matthew L. Trerotola Pres, Chief Executive Officer & Director(age: 58, pay: $2,410,000)
- Mr. Brady R. Shirley Chief Executive Officer of DJO & Executive Vice President(age: 59, pay: $1,440,000)
- Mr. Shyam Kambeyanda Executive Vice President and Chief Executive Officer & Pres of ESAB(age: 54, pay: $1,110,000)
- Mr. Christopher M. Hix Executive Vice President of Fin. & Chief Financial Officer(age: 63, pay: $1,090,000)
- Mr. Daniel A. Pryor Executive Vice President of Strategy & Bus. Devel.(age: 57, pay: $959,000)
- Mr. Mitchell P. Rales Co-Founder & Chairman(age: 68, pay: $1)
-
Is Colfax founder-led company?
Yes, Colfax is a company led by its founder Mr. Mitchell P. Rales.
-
How many employees does Colfax have?
As Jul 2024, Colfax employs 16,200 workers.
-
When Colfax went public?
Colfax Corporation is publicly traded company for more then 17 years since IPO on 8 May 2008.
-
What is Colfax's official website?
The official website for Colfax is colfaxcorp.com.
-
Where are Colfax's headquarters?
Colfax is headquartered at 420 National Business Pkwy Fl 5, Annapolis Junction, MARYLAND.
-
How can i contact Colfax?
Colfax's mailing address is 420 National Business Pkwy Fl 5, Annapolis Junction, MARYLAND and company can be reached via phone at +1 301 323 9000.
Colfax company profile:

Colfax Corporation
colfaxcorp.comNYSE
16,200
Industrial - Machinery
Industrials
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the general industry, construction, infrastructure, transportation, energy, renewable energy, and medical and life sciences markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Wilmington, Delaware.
Annapolis Junction, MARYLAND 19808
CIK: 0001420800
ISIN: US1940141062
CUSIP: 194014106